Fluctuations in lung function vs. asthma control, exacerbations and severity: An alternate look at phenotyping asthma Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010
The evaluation and biomarkers of severe asthma Source: Annual Congress 2010 - Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force Year: 2010
Non-invasive markers of inflammation as a measurement of corticosteroid responsiveness in children with severe asthma (sa) Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Increased levels of angiopoientin-1, angiopoientin-2 in sputum supernatant in severe refractory asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010
How to define clinically relevant phenotypes and endotypes of asthma and COPD Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011
Breathomics for characterizing asthma phenotypes in children Source: Annual Congress 2010 - Paediatric asthma risk factors Year: 2010
Clinically important phenotypes of asthma Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010
Clinical characteristics, lung function, quality of life, exercise capacity and inflammatory biomarkers in induced sputum and serum in children and adolescents with uncontrolled severe asthma. Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Relation of health-related quality of life, frequent exacerbation phenotype and circulating systemic biomarkers in stable COPD Source: Annual Congress 2011 - COPD: mechanisms and biomarker Year: 2011
Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation. Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013
Is infection screening in BAL fluid useful in children with chronic obstructive airway disease unresponsive to anti-asthmatic treatment? Source: Eur Respir J 2006; 28: Suppl. 50, 310s Year: 2006
Chronic rhinosinusitis and airway inflammation in new onset asthma in adults Source: Annual Congress 2011 - Asthma mechanisms Year: 2011
Can flexible combination therapy reduce severe asthma exacerbations associated with common colds? Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010
Clinical control of asthma associated with measures of airway inflammation Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010
Are inflammatory phenotypes in children with severe asthma stable? Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights Year: 2007
Late Breaking Abstract - Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015